DDIAX
Price
$15.34
Change
+$0.02 (+0.13%)
Updated
Jul 21 closing price
Net Assets
836.15M
RLEFX
Price
$36.93
Change
+$0.09 (+0.24%)
Updated
Jul 21 closing price
Net Assets
252.16B
Interact to see
Advertisement

DDIAX vs RLEFX

Header iconDDIAX vs RLEFX Comparison
Open Charts DDIAX vs RLEFXBanner chart's image
Macquarie Wealth Builder A
Price$15.34
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets836.15M
American Funds American Balanced R5E
Price$36.93
Change+$0.09 (+0.24%)
VolumeN/A
Net Assets252.16B
DDIAX vs RLEFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DDIAX vs. RLEFX commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDIAX is a Buy and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 252B vs. DDIAX (836M). RLEFX pays higher dividends than DDIAX: RLEFX (2.01) vs DDIAX (1.44). DDIAX was incepted earlier than RLEFX: DDIAX (29 years) vs RLEFX (10 years). DDIAX (1.09) is less costly to investors than RLEFX (0.39). DDIAX is a more actively managed with annual turnover of: 66.00 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than DDIAX: RLEFX (250) vs DDIAX (1000). RLEFX annual gain was more profitable for investors over the last year : 8.58 vs. DDIAX (3.01). RLEFX return over 5 years is better than : 38.79 vs. DDIAX (29.06).
DDIAXRLEFXDDIAX / RLEFX
Total Expense Ratio1.060.39272%
Annual Report Gross Expense Ratio1.090.39279%
Fund Existence29 years10 years-
Gain YTD5.0378.42960%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets836M252B0%
Annual Yield % from dividends1.442.0171%
Returns for 1 year3.018.5835%
Returns for 3 years15.7234.1346%
Returns for 5 years29.0638.7975%
Returns for 10 years34.36N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SABS2.700.13
+5.06%
SAB Biotherapeutics
LCNB15.520.36
+2.37%
LCNB Corp
AQN6.050.12
+2.02%
Algonquin Power & Utilities Corp
RCUS9.260.11
+1.20%
Arcus Biosciences
JCI108.27-0.69
-0.63%
Johnson Controls International plc